GSK invites private equity bids for older drugs -sources
LONDON, May 29 (Reuters) - GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, according to two people with direct knowledge of the matter. The move is part of a reshaping of the drugmaker's business, which also involves a major asset s
Read more